Main Street Capital Corporation (MAIN) vs United Therapeutics Corporation (UTHR)
MAIN leads on 10 of 14 compared metrics.
A side-by-side comparison of Main Street Capital Corporation and United Therapeutics Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 13, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
MAIN
Main Street Capital Corporation
$52.02Financial Services
UTHR
United Therapeutics Corporation
$545.96Healthcare
Total return — MAIN vs UTHR
growth of $100 · last 19yMAIN +246.8%UTHR +1518.6%UTHR compounded faster
MAIN UTHR
MAIN vs UTHR: by the numbers
- •UTHR is the larger company ($23.17B vs $4.84B market cap).
- •MAIN trades at the lower earnings multiple (10.95 vs 20.18 P/E).
- •MAIN converts more revenue to profit (58.59% vs 40.61% net margin).
- •MAIN grew revenue faster over the past five years (16.32% vs 16.05% CAGR).
- •MAIN pays a dividend (7.75% yield) while UTHR does not currently pay one.
Which is better, MAIN or UTHR?
Metric tally: MAIN 10 · UTHR 4It depends on what you're optimizing for:
ValueMAIN(lower P/E)
QualityUTHR(higher ROIC)
Valuation
| Metric | MAIN | UTHR |
|---|---|---|
| P/E ratio | 10.95● | 20.18 |
| Forward P/E | 13.67● | 16.48 |
| P/S ratio | 6.48● | 8.13 |
| P/B ratio | 1.52● | 4.37 |
| PEG ratio | 0.17● | 1.16 |
| EV / EBITDA | 14.88 | 14.41● |
| FCF yield | 7.26%● | 3.95% |
Profitability
| Metric | MAIN | UTHR |
|---|---|---|
| Gross margin | 86.39% | 86.58% |
| Operating margin | 66.79%● | 45.34% |
| Net margin | 58.59%● | 40.61% |
| ROE | 13.78% | 21.82%● |
| ROIC | 8.64% | 16.14%● |
Dividends
| Metric | MAIN | UTHR |
|---|---|---|
| Dividend yield | 7.75% | — |
| Payout ratio | 73.01% | — |
Growth (annualized)
| Metric | MAIN | UTHR |
|---|---|---|
| Revenue CAGR (5Y) | 16.32% | 16.05% |
| EPS CAGR (5Y) | 65.11%● | 20.93% |
| FCF CAGR (5Y) | 55.68%● | 12.12% |
| Total return CAGR (5Y) | 12.64% | 24.96%● |
Frequently asked
- Which is better, MAIN or UTHR?
- It depends on your goal. value: MAIN (lower P/E); quality: UTHR (higher ROIC). Across all compared metrics, MAIN leads 10 to 4.
- Is MAIN or UTHR cheaper?
- On trailing earnings, MAIN is cheaper: MAIN trades at a 10.95 P/E and UTHR at 20.18.
- Which has grown faster, MAIN or UTHR?
- Over the past five years, MAIN grew revenue faster — MAIN at a 16.32% CAGR versus UTHR at 16.05%.
- Does MAIN or UTHR pay a bigger dividend?
- MAIN pays a dividend (7.75% yield) while UTHR does not currently pay one.
- Is MAIN or UTHR more profitable?
- MAIN runs the higher net margin — MAIN at 58.59% versus UTHR at 40.61%.
- Which has been the better investment, MAIN or UTHR?
- Over the past 10-year, UTHR delivered the higher annualized total return — MAIN at 13.03% versus UTHR at 17.22%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Main Street Capital P/E ratioUnited Therapeutics P/E ratioMain Street Capital dividend yieldUnited Therapeutics dividend yieldMain Street Capital ROEUnited Therapeutics ROEMain Street Capital operating marginUnited Therapeutics operating marginMain Street Capital revenue growthUnited Therapeutics revenue growthMain Street Capital free cash flowUnited Therapeutics free cash flow
Main Street Capital & United Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 13, 2026.